000 01473 a2200457 4500
005 20250516124549.0
264 0 _c20130604
008 201306s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2012.363
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrivtsov, A V
245 0 0 _aCell of origin determines clinically relevant subtypes of MLL-rearranged AML.
_h[electronic resource]
260 _bLeukemia
_cApr 2013
300 _a852-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCytarabine
_xpharmacology
650 0 4 _aGene Expression Profiling
650 0 4 _aHistone-Lysine N-Methyltransferase
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMyeloid-Lymphoid Leukemia Protein
_xgenetics
700 1 _aFigueroa, M E
700 1 _aSinha, A U
700 1 _aStubbs, M C
700 1 _aFeng, Z
700 1 _aValk, P J M
700 1 _aDelwel, R
700 1 _aDöhner, K
700 1 _aBullinger, L
700 1 _aKung, A L
700 1 _aMelnick, A M
700 1 _aArmstrong, S A
773 0 _tLeukemia
_gvol. 27
_gno. 4
_gp. 852-60
856 4 0 _uhttps://doi.org/10.1038/leu.2012.363
_zAvailable from publisher's website
999 _c22342158
_d22342158